Skip to main content
Shenzhen Salubris Pharmaceuticals Co., Ltd. logo

Shenzhen Salubris Pharmaceuticals Co., Ltd. — Investor Relations & Filings

Ticker · 002294 ISIN · CNE100000FW8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,658 across all filing types
Latest filing 2016-03-21 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002294

About Shenzhen Salubris Pharmaceuticals Co., Ltd.

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a research-driven enterprise focused on the development, manufacturing, and commercialization of innovative drugs and medical devices. The company specializes in therapeutic areas including cardiovascular diseases, chronic kidney disease, and metabolic disorders. Its product portfolio features proprietary treatments such as Allisartan Isoproxil for hypertension and Clopidogrel Bisulfate for anti-platelet therapy. Salubris maintains an integrated value chain encompassing research and development, active pharmaceutical ingredient production, and finished dosage manufacturing. The firm emphasizes innovation through its dedicated R&D centers and strategic focus on biologics and small molecule drugs, aiming to provide comprehensive clinical solutions for chronic conditions.

Recent filings

Filing Released Lang Actions
第三届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shenzhen Salubris Pharmaceuticals Co., Ltd. regarding the approval of the 2015 Supervisory Board Work Report, the 2015 Annual Report and its summary, the 2015 profit distribution plan, and the 2015 internal control self-evaluation report. The document states these reports will be submitted to the 2015 Annual General Meeting for approval and provides links to the full reports on external websites. The document itself does not contain the full annual report or detailed financial statements but rather announces the resolutions and approvals made by the Supervisory Board. The document length is 2460 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document is an announcement of the report and related resolutions, not the report itself. Hence, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories.
2016-03-21 Chinese
2015年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It contains detailed financial statements including consolidated and company balance sheets, profit and loss statements, cash flow statements, and changes in shareholders' equity for the fiscal year ending December 31, 2015. The document includes an auditor's opinion section, responsibilities of management and auditors, and detailed financial data. The length is substantial (15,000 characters) and it contains the full audit report and financial statements, not just an announcement or certification. Therefore, this document fits the category of a standalone Audit Report / Information filing rather than a full Annual Report or other categories. FY 2015
2016-03-21 Chinese
内部控制规则落实自查表
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制规则落实自查表" which translates to "Internal Control Rules Implementation Self-Inspection Form." It contains detailed internal control checklists related to internal audit operations, information disclosure, insider trading controls, fundraising controls, related party transactions, external guarantees, major investments, and other important matters. The document includes specific internal control procedures, compliance checks, and audit-related self-assessment items. It is not a financial report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. It is a detailed internal control audit or self-assessment report, which aligns with the category of Audit Report / Information (AR) as it relates to internal control audit results and compliance checks. The document length is 4236 characters, which is substantive and contains detailed content rather than a brief announcement. Therefore, the best fitting classification is AR (Audit Report / Information). FY 2015
2016-03-21 Chinese
第三届董事会第十三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Shenzhen Xinlitai Pharmaceutical Co., Ltd. It includes approvals of the 2015 annual general manager work report, board work report, 2015 annual report and its summary, profit distribution plan, appointment of auditors, internal control self-assessment report, and other corporate governance matters. The document references the 2015 annual report multiple times and states that these reports will be submitted to the 2015 annual shareholders meeting for approval. The document is not the annual report itself but a formal announcement of board meeting decisions related to the annual report and other governance matters. The length is under 5,000 characters, and it primarily serves as a meeting resolution announcement rather than containing full financial statements or detailed report content. Therefore, it fits best as a Regulatory Filing (RNS) rather than the Annual Report (10-K) or Management Reports (MDA).
2016-03-21 Chinese
关于举行2015年年度报告网上说明会的公告
AGM Information Classification · 95% confidence The document is an announcement about holding an online explanation meeting for the 2015 annual report. It specifies the date and time of the meeting and invites investors to participate. The document does not contain the annual report itself or detailed financial data, but rather informs about a presentation related to the annual report. Given the short length (462 characters) and the nature of the content, this fits the category of AGM Information (AGM-R), which includes presentations and materials shared during annual general meetings or related explanatory meetings.
2016-03-21 Chinese
2015年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2015 Annual Supervisory Board Work Report" of Shenzhen Salubris Pharmaceuticals Co., Ltd. It details the supervisory board's activities during 2015, including oversight of quarterly and half-year reports, internal controls, financial audits, and compliance with laws and regulations. It references the review and supervision of the 2015 quarterly reports, half-year report, and annual report, but does not itself contain the full financial statements or detailed financial data. The document is a supervisory board report summarizing oversight activities rather than a full annual report or interim report. It is not a short announcement or certification but a detailed supervisory report. This fits best under Audit Report / Information (AR), which includes reports on applied accounting principles, audit results, and supervisory board work reports related to financial and internal control oversight, excluding full annual reports. The document length (3437 characters) and content support this classification rather than Annual Report (10-K) or Interim Report (IR). FY 2015
2016-03-21 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.